Phramalive.com – SANTA CLARA, Calif.–(BUSINESS WIRE)–Feb 6, 2007 – Affymetrix, Inc. (Nasdaq:AFFX) wishes to issue the following update to its release BW5349 (CA-AFFYMETRIX) “Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology
Midday Leaders & Laggards: Nasdaq 100
Boston Globe – On the positive side, a JPMorgan analyst’s upgrade to “Overweight” from “Neutral” sent shares of graphics chip maker Nvidia Corp. up 84 cents, or 2.6 percent, to $33.21. An upgrade from Merrill Lynch to “Buy” from “Neutral” sent shares of
Ares Capital Prices 1.2M Share Offering
Forbes – Investment company Ares Capital Corp. said Tuesday it will sell about 1.2 million shares of common stock in a public offering at $19.95 per share. The company expects to raise about $24 million in proceeds. Merrill Lynch, Pierce, Fenner & Smith Inc
Medicis to Present At Merrill Lynch Global Pharmaceutical
Financial News USA – City of Industry, CA –(www.FinancialNewsUSA.com)– 02/05/2007 – Biotechnology industry news provided by Financial News USA (OTC: FNWU). Medicis (NYSE:MRX) recently announced that the Company is scheduled to present at the Merrill Lynch Global
Report: SEC probing Wall St. leaks
MSNBC – The SEC sent similar requests to Merrill Lynch, Morgan Stanley and Deutsche Bank , The Times reported, citing a Wall Street employee. UBS, Morgan Stanley and Merrill Lynch declined to comment on the report. Deutsche Bank officials were not immediately
Arch Capital Group Ltd. to Present at Merrill Lynch Insurance
MSN MoneyCentral – Arch Capital Group Ltd. ACGL today announced that Constantine (Dinos) Iordanou, President and Chief Executive Officer of Arch Capital Group Ltd., is scheduled to present at the Merrill Lynch Insurance Investors Conference in New York. The